Bioequivalence study of two oral formulations of paracetamol

The pharmaceutical preparations of paracetamol Duorol and Termalgin, both containing 500 mg of active compound, were studied to test their bioequivalence. The results obtained showed that absorption of the drug follows two sequential kinetic processes by their corresponding first order rate constant...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of clinical pharmacology, therapy, and toxicology Vol. 26; no. 5; p. 232
Main Authors Pedraz, J L, Alonso, E, Calvo, M B, Lanao, J M, Dominguez-Gil, A
Format Journal Article
LanguageEnglish
Published Germany 01.05.1988
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:The pharmaceutical preparations of paracetamol Duorol and Termalgin, both containing 500 mg of active compound, were studied to test their bioequivalence. The results obtained showed that absorption of the drug follows two sequential kinetic processes by their corresponding first order rate constants (K1 and K2) with values of 0.31, 5.69 and 0.30, 5.71 h-1 for Duorol and Termalgin, respectively. Analysis of variance showed that there were no statistically significant differences (p greater than 0.5) in the absorption, biotransformation and excretion processes between the two preparations assayed. Finally, the use of symmetric confidence intervals by the Westlake test, showed that both preparations are bioequivalent.
ISSN:0174-4879